Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.4622
-0.0182 (-3.79%)
At close: Jan 9, 2026, 4:00 PM EST
0.4622
0.00 (0.00%)
Pre-market: Jan 12, 2026, 8:05 AM EST
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $6.18 million as of January 12, 2026.
Market Cap
6.18M
Enterprise Value
6.27M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since August 15, 2025, Propanc Biopharma's market cap has decreased from $36.20M to $6.18M, a decrease of -82.94%. That is a compound annual growth rate of -98.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 6.20M | -13.89% |
| Dec 31, 2025 | 7.20M | -80.11% |
| Aug 15, 2025 | 36.20M | - |
View and export this data all the way back to 2025. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |